Logo-npj

Review

1. Diabetic kidney disease: world wide difference of prevalence and risk factors
Osama Gheith*, Nashwa Farouk, Narayanan Nampoory, Medhat A Halim, Torki Al-Otaibi
J Nephropharmacol. 2016;5(1): 49-56.
Article
PDF
XML
Cited By:
Original

2. Oral repaglinide versus insulin injection in type II diabetes mellitus; a randomized clinical trial
Hosein Chiti, Maryam Hajipour Manjili, Aiyoub Pezeshgi, Seyednouraddin Mousavinasab, Zahra Abbaspour, Masoud Asadi-Khiavi*
J Nephropharmacol. 2017;6(2): 156-159. doi: 10.15171/npj.2017.25
Article
PDF
XML
Cited By:
0
Editorial

3. Hyperuricemia; a warning sign of future cardiovascular events and chronic kidney disease
Farahnak Assadi*
J Nephropharmacol. 2018;7(1): 1-2. doi: 10.15171/npj.2018.01
Article
PDF
XML
Cited By:
0